8964.T
Mitsui Fudosan Retail Fund Investment Corporation
TokyoJPYEQUITY
Real Estate
DELAYED
Last price
79,300.00
▲ 300.00 (0.38%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
79,100.00
Prev close
79,000.00
Day high
79,400.00
Day low
78,700.00
Volume
4.39K
Market cap
$214.51B
P/E (TTM)
18.18
52W range
77,600.00 – 95,900.00
Day trading desk
Gap from prior close
+0.13%
Prior close 79,000.00
VWAP
79,157.33
+0.18% from price
Relative volume
0.53×
Quiet session
Session range
0.89%
78,700.00 – 79,400.00
Position in range
86%
Near session high
ATR (14D)
964.29
1.22% of price
Prior day high
79,100.00
PDH
Prior day low
78,500.00
PDL
Bid / ask spread
—
Quote not published
Session volume
4.22K
Avg 8.03K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-0.50%
+0.9%
1M
-3.29%
-7.0%
3M
-3.06%
-6.2%
6M
-12.38%
-23.4%
YTD
-14.73%
-27.0%
1Y
-9.37%
-29.4%
3Y
-16.70%
-90.9%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on 8964.T open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
145.99K
Total on file
Fundamentals
Market cap$214.51B
Enterprise value$325.43B
Revenue (TTM)$24.45B
Gross profit$13.39B
EBITDA$17.28B
Net income$11.90B
EPS (TTM)$4,360.80
Free cash flow—
Total cash$6.16B
Total debt$117.90B
Book value / share$64,893.36
Shares outstanding2.71M
Float2.56M
Short % of float—
Dividend yield5.62%
Beta (5Y)0.12
Valuation & profitability ratios
Trailing P/E18.18
Forward P/E3.73
PEG ratio20.43
Price / sales—
Price / book1.22
EV / revenue13.31
EV / EBITDA18.84
Gross margin54.76%
Operating margin54.43%
Profit margin48.66%
Return on equity6.78%
Return on assets2.32%
Debt / equity74.10
Current ratio0.61
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $23.82B | $24.45B | $22.56B | $22.96B | — | -2.6% |
| Operating revenue | $23.82B | $24.45B | $22.56B | $22.96B | — | -2.6% |
| Cost of revenue | $10.80B | $10.44B | $9.82B | $9.99B | — | +3.5% |
| Gross profit | $13.02B | $14.01B | $12.74B | $12.97B | — | -7.1% |
| Selling, general & admin | $56.77M | $53.47M | $49.94M | $52.02M | — | +6.2% |
| Total operating expense | $332.75M | $341.56M | $315.20M | $324.72M | — | -2.6% |
| Operating income | $12.69B | $13.67B | $12.43B | $12.64B | — | -7.2% |
| Net interest income | -$877.35M | -$674.54M | -$557.33M | -$531.18M | — | -30.1% |
| Pre-tax income | $11.79B | $12.93B | $11.85B | $12.07B | — | -8.8% |
| Tax provision | $1.76M | $1.66M | $1.78M | $1.71M | — | +6.5% |
| Net income | $11.79B | $12.93B | $11.85B | $12.07B | — | -8.8% |
| Net income to common | $11.79B | $12.93B | $11.85B | $12.07B | — | -8.8% |
| Basic EPS | 4,358.20 | — | 4,380.66 | — | 4,346.03 | — |
| Diluted EPS | 4,358.20 | — | 4,380.66 | — | 4,344.73 | — |
| EBIT | $12.68B | $13.60B | $12.40B | $12.60B | — | -6.8% |
| EBITDA | $16.68B | $17.54B | $16.20B | $16.60B | — | -4.9% |
| Basic shares | 2.71M | — | 2.71M | — | 2.63M | — |
| Diluted shares | 2.71M | — | 2.71M | — | 2.63M | — |
| Line item | 2025 | 2024 | 2023 | 2021 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $12.13B | $12.86B | $13.53B | $8.10B | -5.7% |
| Cash & short-term investments | $12.13B | $12.86B | $13.53B | $8.10B | -5.7% |
| Accounts receivable | $118.47M | $126.37M | $118.12M | $126.35M | -6.3% |
| Total current assets | $16.78B | $16.80B | $18.49B | $12.71B | -0.1% |
| Property, plant & equipment | $324.38B | $314.75B | $316.04B | $315.57B | +3.1% |
| Goodwill & intangibles | $1.66B | $1.66B | $1.66B | $1.66B | -0.0% |
| Total assets | $342.89B | $333.31B | $336.33B | $330.06B | +2.9% |
| Total current liabilities | $17.94B | $16.20B | $18.81B | $14.26B | +10.8% |
| Current debt | $15.00B | $13.00B | $14.90B | $11.50B | +15.4% |
| Long-term debt | $122.70B | $114.70B | $115.20B | $111.90B | +7.0% |
| Total debt | $137.70B | $127.70B | $130.10B | $123.40B | +7.8% |
| Total liabilities | $167.31B | $157.66B | $161.94B | $155.61B | +6.1% |
| Retained earnings | $5.88B | $6.50B | $5.70B | $5.94B | -9.5% |
| Shareholder equity | $175.58B | $175.65B | $174.39B | $174.45B | -0.0% |
| Working capital | -$1.17B | $602.70M | -$319.91M | -$1.54B | -294.0% |
| Net tangible assets | $173.92B | $173.99B | $172.73B | $172.78B | -0.0% |
| Shares issued | 2.71M | 2.71M | 2.71M | 2.71M | 0.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $11.79B | $12.93B | $11.85B | $12.07B | -8.8% |
| Depreciation & amortisation | $4.01B | $3.93B | $3.80B | $4.00B | +1.9% |
| Change in working capital | $576.86M | $844.39M | -$959.19M | $405.11M | -31.7% |
| Operating cash flow | $16.36B | $21.14B | $21.15B | $19.28B | -22.6% |
| Capital expenditure | -$12.16B | -$6.91B | -$15.79B | -$636.59M | -76.0% |
| Investing cash flow | -$12.62B | -$7.78B | -$16.36B | -$1.52B | -62.2% |
| Dividends paid | -$11.90B | -$11.67B | -$12.03B | -$11.95B | -1.9% |
| Financing cash flow | -$1.90B | -$14.07B | -$5.13B | -$12.15B | +86.5% |
| Free cash flow | $4.19B | $14.23B | $5.37B | $18.64B | -70.5% |
| End cash position | $34.46B | $32.97B | $40.06B | $32.20B | +4.5% |
No filings published for this symbol yet.
Newly listed companies often have nothing on file until their first annual report.
Newly listed companies often have nothing on file until their first annual report.
| Line item | 2025-12-31 | 2025-06-30 | 2024-12-31 | YoY |
|---|---|---|---|---|
| Cash & equivalents | $12.13B | $12.13B | $12.86B | 0.0% |
| Cash & short-term investments | $12.13B | $12.13B | $12.86B | 0.0% |
| Accounts receivable | $118.47M | $118.47M | $126.37M | 0.0% |
| Total current assets | $16.78B | $16.78B | $16.80B | 0.0% |
| Property, plant & equipment | $324.38B | $324.38B | $314.75B | 0.0% |
| Goodwill & intangibles | $1.66B | $1.66B | $1.66B | 0.0% |
| Total assets | $342.89B | $342.89B | $333.31B | 0.0% |
| Total current liabilities | $17.94B | $17.94B | $16.20B | 0.0% |
| Current debt | $15.00B | $15.00B | $13.00B | 0.0% |
| Long-term debt | $122.70B | $122.70B | $114.70B | 0.0% |
| Total debt | $137.70B | $137.70B | $127.70B | 0.0% |
| Total liabilities | $167.31B | $167.31B | $157.66B | 0.0% |
| Retained earnings | $5.88B | $5.88B | $6.50B | 0.0% |
| Shareholder equity | $175.58B | $175.58B | $175.65B | 0.0% |
| Working capital | -$1.17B | -$1.17B | $602.70M | 0.0% |
| Net tangible assets | $173.92B | $173.92B | $173.99B | 0.0% |
| Shares issued | 2.71M | 2.71M | 2.71M | 0.0% |
No filings published for this symbol yet.
Newly listed companies often have nothing on file until their first annual report.
Newly listed companies often have nothing on file until their first annual report.
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $0 | — |
| Next quarter | — | — | $0 | — |
| Current year | — | — | $0 | — |
| Next year | — | — | $0 | — |
Analyst targets & ownership
Mean target$98,800.00
High target$105,000.00
Low target$94,000.00
Implied upside24.59%
Analyst count5
ConsensusHOLD
Strong buy / Buy0 / 1
Hold4
Sell / Strong sell0 / 0
Held by insiders5.40%
Held by institutions60.84%
Institutions holding119
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
79,410.00
-0.14% from price
SMA 20
80,580.00
-1.59% from price
SMA 50
80,956.00
-2.05% from price
SMA 100
82,698.00
-4.11% from price
SMA 200
87,262.00
-9.12% from price
EMA 12
79,608.06
-0.39% from price
EMA 26
80,336.09
-1.29% from price
EMA 50
81,118.31
-2.24% from price
RSI (14)
42.2
Neutral
MACD (12,26,9)
-728.02
Hist -139.88
ATR (14)
964.29
1.22% of price
Realised vol 30D
15.5%
Annualised
Bollinger upper
84,178.11
20, 2σ
Bollinger lower
76,981.89
20, 2σ
50 / 200 cross
Death
80,956.00 vs 87,262.00
Trend bias
Below 200
-9.12%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
-0.19
Less volatile than market
Correlation to SPY
-0.18
Largely independent
Realised vol 30D
15.5%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-17.9%
Peak to trough
Max drawdown 5Y
-30.0%
Peak to trough
ATR 14
964.29
1.22% of price
Beta (reported)
0.12
5Y monthly, from filing
Dividends & splits
Forward rate$4,440.00 / yr
Forward yield5.62%
5-year avg yield4.81%
Payout ratio100.96%
Ex-dividend dateDec 29, 2026
Next pay date—
Last split5:1
Split dateDec 27, 2024
Headlines
3 Unpopular Stocks We Steer Clear Of
StockStory · 9m ago
Oleria and Happiest Minds Partner to Accelerate Modern Identity Governance for AI-First Enterprises
ACCESS Newswire · 12m ago
Vicore Pharma to Present at the European Respiratory Society Congress 2026
ACCESS Newswire · 12m ago
Dollar trading near multi-month lows, restrained by debt nerves
Reuters · 12m ago
Billionaire Investor Stanley Druckenmiller Sold Broadcom, Intel, and Micron and Bought Another Chip Stock That Expects to Double Data Center Sales in 2027
Motley Fool · 22m ago
TME Pharma provides update on its activities
GlobeNewswire · 22m ago
American Chemical Society Names Syngenta's Camilla Corsi the 2026 Winner of Prestigious International Award for Research in Agrochemicals
Business Wire · 27m ago
Valerio Therapeutics Announces Signing of Definitive Agreements for the Acquisition of Etherna Immunotherapies, Building a Leading Platform in Targeted RNA, and €40.25 Million PIPE Financing From New and Existing Investors
Business Wire · 27m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.